Identity
- Trade Name
- CHATTANOOGA FDA UDI
- Generic Name
- Analytical non-scalp cutaneous lead FDA UDI
- Device Name
- CABLE ASSY EMG CH2 FDA UDI
- Model / Reference
- 27322 FDA UDI
- Description
- CABLE ASSY EMG CH2 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00888912291873 FDA UDI
- FDA Product Code
- IKD FDA UDI
- GMDN Term
- Analytical non-scalp cutaneous lead FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 890.1175 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Analytical non-scalp cutaneous lead
Chattanooga by Djo, Llc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Analytical non-scalp cutaneous lead.
- Chalgren — Chalgren Enterprises, Inc. · Class II
- Chalgren — Chalgren Enterprises, Inc. · Class II
- Natus — Natus Neurology Incorporated · Class II
- Rhythmlink® — Rhythmlink International, LLC · Class II
- Chalgren — Chalgren Enterprises, Inc. · Class II
- Sanibel Supply A/S — Interacoustics A/S · Class II
- Ambu Neuroline Concentric Cable, Lenght of leadwire: 200 cm (79") — Ambu A/S · Class II
- Rhythmlink® — Rhythmlink International, LLC · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Djo, Llc
Sources (1)
- FDA UDI 013a5e2c-add9-458e-ad82-d809792d52d6 33 fields · synced Jun 8, 2026